Site intended for healthcare professionals only
The summary presented herein represents Part II of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients with castration-resistant disease. Please refer […]
» Read moreThe summary presented herein represents Part I of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients with biochemical recurrence without metastatic […]
» Read moreDespite being the most frequent renal fusion anomaly, tumors arising from horseshoe kidneys (HSKs) are extremely rare and management guidance is lacking.To evaluate the perioperative, oncological, and functional outcomes of […]
» Read moreSentinel node (SN) biopsy in penile cancer (PeCa) is typically performed using 99mTc-nanocolloid and blue dye. Recent reports suggested that the hybrid (radioactive and fluorescent) tracer indocyanine green (ICG)-99mTc-nanocolloid may […]
» Read moreWe previously reported that olaparib led to significantly longer imaging-based progression-free survival than the physician’s choice of enzalutamide or abiraterone among men with metastatic castration-resistant prostate cancer who had qualifying […]
» Read moreThe feasibility and efficacy of robot-assisted radical prostatectomy (RARP) in locally advanced prostate cancer (PCa) patients with iT3 lesion at magnetic resonance imaging (MRI) are currently not explored.To describe our […]
» Read moreActive surveillance (AS) is an accepted management strategy for some patients with renal cell carcinoma, but limited tools are available to identify optimal AS candidates. While renal mass biopsy provides […]
» Read moreObesity is a well-known risk factor for kidney cancer incidence. However, a number of studies have demonstrated more favorable kidney cancer prognosis in patients with elevated body mass index (BMI) […]
» Read moreThe incidence of UTIs is seasonal, peaking in summer months. One possible mechanism for the observed seasonality of UTIs is warmer weather.We identified all UTI cases located in approximately 400 […]
» Read moreThere have been concerns about higher incidence of local and retroperitoneal recurrences after robot-assisted radical cystectomy (RARC) compared to open radical cystectomy. We sought to report and detail relapses following […]
» Read moreTo determine the efficacy of dried cranberry on reducing symptoms of overactive bladder in women.Eligible women aged 18 or older with overactive bladder were randomized to either daily dried cranberry […]
» Read moreProstate cancer is predominantly indolent at diagnosis with a small fraction (15-25%) representing aggressive subtype [Gleason score (GS) 7-10], which is prone to metastatic progression. It is critical to explore […]
» Read moreTivozanib is a potent and selective inhibitor of the VEGF receptor. In an open-label, randomized phase 3 trial, we compared tivozanib to sorafenib in patients with metastatic renal cell carcinoma […]
» Read moreThe aim of the study is to report the reliability of computed tomography urography (CTU) and ureteroscopy (URS) in the diagnosis and management of UTUC.From 2015 to 11/2018, we prospectively […]
» Read moreRestaging of prostate cancer in patients with biochemical recurrence (BCR) after radical treatment remains a challenging clinical scenario as current imaging modalities are suboptimal. To date, PSMA PET/CT seems to […]
» Read moreTo report on comparative effectiveness of minimally invasive versus traditional open kidney transplantation.We undertook a prospective cohort study of 654 patients who underwent open or robotic kidney transplantation at a […]
» Read moreLittle is understood about physiologic and psychologic correlates of erectile dysfunction (ED) among younger men. This study examined prevalence and correlates of ED in a large US sample of 18-31 […]
» Read moreCurrent first-line treatment options in patients with metastatic urothelial carcinoma (mUC) unfit to receive cisplatin-containing chemotherapy include PD-1/L1 inhibitors and carboplatin-containing chemotherapy. However, the optimal sequencing of these therapies remains […]
» Read moreThis study aims to evaluate the impact of psychological intervention with parents of enuretic children on treatment outcome.Sixty-six enuretic children were randomized into two groups. All children received urotherapy orientation […]
» Read moreMost international practice guidelines recommend screening for chronic kidney disease among older men with lower urinary tract symptoms. However, prior studies supporting these guidelines are insufficient due to incomplete assessments […]
» Read moreThe relationship between fluid intake and lower urinary tract symptoms (LUTS) in individuals with neurogenic bladder is unknown. We aimed to investigate the association between fluid intake and urinary symptoms […]
» Read moreTo evaluate the real-world effectiveness of regimented phosphodiesterase type 5 inhibitor (regPDE5i) dosing on recurrent ischemic priapism (RIP) outcomes, using emergency department (ED) visits as a proxy for therapeutic control […]
» Read moreCancer-specific survival for men with early-stage (Stage I-IIB) testicular germ cell tumors (TGCT) is greater than 90% with any management strategy. The data regarding the comparative effectiveness of surveillance, primary […]
» Read moreThe phase 3 SPARTAN study evaluated apalutamide versus placebo in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) and prostate-specific antigen doubling time of ≤10 mo. At primary analysis, apalutamide improved […]
» Read moreTo examine the association of race/ethnicity with urinary incontinence subtypes and overactive bladder and associated bother in older men.This cross-sectional analysis utilized data from Multi-Ethnic Study of Atherosclerosis, an observational […]
» Read moreLife expectancy has become a core consideration in prostate cancer care. While multiple prediction tools exist to support decision-making, their discriminative ability remains modest, which hamper usage and utility. We […]
» Read moreDarolutamide is a structurally distinct androgen-receptor inhibitor that is approved for the treatment of nonmetastatic, castration-resistant prostate cancer. In the planned primary analysis of a phase 3 trial, the median […]
» Read moreWe evaluated mid urethral sling outcomes in overweight and obese patients compared to normal weight patients and identified risk factors for failure in this population.Records of 688 women between January […]
» Read moreWe report outcomes of hemigland high intensity focused ultrasound ablation as primary treatment for localized prostate cancer in the United States.A total of 100 consecutive men underwent hemigland high intensity […]
» Read moreAscending testes has been documented to be descended in scrotum within the first year of life and then re-ascended. The aim of the study was to investigate to what extend […]
» Read more